https://alsnewstoday.com/news/results-phase-3-trial-tudca-als-likely-next-year/
Findings from the TUDCA-ALS trial in 337 adults, testing oral TUDCA plus riluzole in slowing ALS progression, are likely in late 2023.
Create an account or login to join the discussion